Monika Sztankay
Biographic Data
| ID | 7688992 |
|---|---|
| NAME | Monika Sztankay |
| GIVEN NAMES | Monika |
| FAMILY NAME | Sztankay |
| SIGNATURE | SZTANKAY M |
| AFFILIATIONS | Innsbruck Medical University |
| ORCID | 0000-0002-7938-1250 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Assessing the assessment
Despite clear guidelines, reporting of the mode of PRO assessment remains inadequate, and active review of PRO data is uncommon. Strengthening transparency and using PROs more actively within trials could enhance patient-centered cancer research
Development of an EORTC questionnaire measuring instrumental activities of daily living (Iadl) in patients with brain tumours
A phase IV validation study is needed to confirm the psychometric properties of the EORTC IADL-BN32 questionnaire in a larger international sample
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
This study provides four new EORTC modules for use in clinical research and routine practice in conjunction with the EORTC QLQ-C30 for assessing QoL in patients with lymphoma and CLL
No prominent works on this page.
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
This study provides four new EORTC modules for use in clinical research and routine practice in conjunction with the EORTC QLQ-C30 for assessing QoL in patients with lymphoma and CLL
Development of an EORTC questionnaire measuring instrumental activities of daily living (Iadl) in patients with brain tumours
A phase IV validation study is needed to confirm the psychometric properties of the EORTC IADL-BN32 questionnaire in a larger international sample
Assessing the assessment
Despite clear guidelines, reporting of the mode of PRO assessment remains inadequate, and active review of PRO data is uncommon. Strengthening transparency and using PROs more actively within trials could enhance patient-centered cancer research
Quality of life (healthcare (3 works) · Cancer survivorship and care (2 works) · Medicine (2 works) · Public health (2 works) · Quality of Life Research (2 works) · Activities of daily living (1 works) · Cancer (1 works) · Cancer Treatment and Pharmacology (1 works) · Cancer-related cognitive impairment studies (1 works) · Chronic lymphocytic leukemia (1 works)